23.10.2013 Views

Aktivitet Prosj. nr. Hovedinstitusjon Prosjekt- ansvarlig 1 Prosjekt ...

Aktivitet Prosj. nr. Hovedinstitusjon Prosjekt- ansvarlig 1 Prosjekt ...

Aktivitet Prosj. nr. Hovedinstitusjon Prosjekt- ansvarlig 1 Prosjekt ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

BIOFYS 167113 Universitetet i Tromsø<br />

Legemiddelteknolo<br />

gi og biofarmasi<br />

BIOFYS 167147 Universitetet i Oslo Rikshospitalet HF Institutt for Patologi<br />

BIOFYS 167164 Universitetet i Bergen<br />

Norges<br />

BIOFYS 167169 landbrukshøgskole<br />

Institutt for<br />

Indremedisin<br />

BIOFYS 167182 Universitetet i Oslo Fysiologisk institutt<br />

BIOFYS 167198 Universitetet i Tromsø Institutt for Farmasi<br />

BIOFYS 167200 Universitetet i Oslo Anatomisk institutt<br />

BIOFYS 167208 Universitetet i Oslo Fysiologisk institutt<br />

BIOFYS 167267 Universitetet i Oslo Fysiologisk institutt<br />

BIOFYS 167269 Universitetet i Oslo Rikshospitalet HF<br />

BIOFYS 167271 Universitetet i Bergen<br />

BIOFYS 167274 Veterinærinstituttet Oslo<br />

Institutt for<br />

biomedisin<br />

BIOFYS 167275 Universitetet i Bergen Institutt for biologi<br />

Pediatrisk<br />

forskningsinstitutt<br />

Computer-Aided Design of<br />

Peptidomimetic<br />

Antagonists of the CXCR4<br />

Chemokine Receptor, a<br />

Therapeutic Target for<br />

Oncology and AIDS<br />

Dysregulation of<br />

Differentiation in Disease<br />

Development<br />

Establishment of a<br />

Norwegian technologyknowledge<br />

platform for<br />

testing-isolationcharacterization<br />

of<br />

bioactivities of natural<br />

compounds<br />

Functional Food Science.<br />

Food science aligned to<br />

nutrition and medicine.<br />

Multilevel analysis of<br />

memory formation in the<br />

entorhinal-hippocampal<br />

circuit<br />

Drug Transport and Drug<br />

Delivery: “Approaches to<br />

overcome poor<br />

bioavailability of drugs”<br />

Gene disruption of<br />

neurotransmitter<br />

transporter proteins<br />

involved in normal synaptic<br />

transmission and pathology<br />

Dynamics of sensory input<br />

to cerebral cortex in normal<br />

and epileptic brain<br />

Strategies for reducing<br />

injury in the acute and<br />

chronically ischemic<br />

myocardium<br />

Cell injury and programmed<br />

cell death. Significance in<br />

pediatric diseases<br />

Mechanisms of Tumor<br />

Angiogenesis and New<br />

Therapeutic Principles<br />

Brucella-infections in seals,<br />

mice and man: Zoonotic<br />

potential of marine Brucella<br />

sp. and the combined effect<br />

of infection and exposure<br />

POPs<br />

Endogenous intracellular<br />

protein transformation and<br />

utilisation during marine<br />

fish development<br />

Hans<br />

Hellebostad<br />

Hans<br />

Hellebostad<br />

Hans<br />

Hellebostad<br />

Hans<br />

Hellebostad<br />

Hans<br />

Hellebostad<br />

Hans<br />

Hellebostad<br />

Hans<br />

Hellebostad<br />

Hans<br />

Hellebostad<br />

Hans<br />

Hellebostad<br />

Hans<br />

Hellebostad<br />

Hans<br />

Hellebostad<br />

Hans<br />

Hellebostad<br />

Hans<br />

Hellebostad

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!